About Us

Our vision is to create a greener future with sustainable particle technology.

Who We Are

Naturbeads began with a spark of curiosity at the University of Bath. Professors Janet Scott and Davide Mattia were exploring sustainable materials when they stumbled upon a way to turn cellulose — the most abundant natural polymer on Earth — into perfectly round, biodegradable microspheres. What started as a lab experiment quickly drew real-world attention: after sending a few grams of their first sample to a major cosmetics company, the reply came back almost instantly — “Thanks… now can we have a kilogram?”

Recognising the potential to replace billions of microplastics polluting our planet, Janet, Davide, and Giovanna Laudisio founded Naturbeads in 2018 as a spin-out from the University of Bath. With early support from the University’s Centre for Sustainable and Circular Technologies (CSCT) and our first investment in 2019, we’ve since grown from lab discovery to building our first production plant — scaling a simple but powerful idea: replacing microplastics with nature.

707da4_641ad98b6e7e489ab6f334eb7b9e09b0~mv2.avif

Key Milestones

Before 2018

Research into the cellulose-based technology for replacing microplastics began at the University of Bath, supported by the CSCT.

2018

Naturbeads was incorporated as a spin-out company from the University of Bath.

2019

Secured funding from Innovate UK and Sky Ocean Ventures.

2022

Raised £1.3 million in funding to move from pilot to demo-scale production.

2024

Secured a major Series A funding round of £7.8 million to construct our first production plant.

2025

Operating our first commercial plant.

Our Vision

To create a greener future with sustainable particle technology.

Our Mission

At Naturbeads, our mission is to make sustainability effortless by developing innovative, cost-competitive technologies that replace harmful microplastics with natural, biodegradable alternatives.

Our Commitment

At Naturbeads, we believe in a future where nature, not plastic, shapes the materials we use every day. We’re a passionate, purpose-driven team working to replace harmful ingredients with sustainable, circular, and biodegradable solutions that perform just as well with the same cost of plastics without costing the Earth. Guided by innovation, integrity, and collaboration, we’re building this future together with our partners, for the planet and for generations to come.

Past projects – Exploitation phase

Cellulozyme Project

Naturbeads worked together with industrial partner Chiral Vision (Netherlands) to develop and test a platform of prototype carriers for enzyme immobilization. Our carriers can successfully immobilize lipase, glucose amylase, urease, oxo-reductase, protease, glucose oxidase.

The collaboration between Naturbeads and Chiral Vision continues with the ambition to scale up our first prototype for home dialysis applications together with Next Kidney. We applied for an EIC grant to support the scale up and testing at pilot scale. Results expected Dec 2025

Edible microcarriers for the cultured meat industry

Past project - cultured meat with caption.png

past project - cultured meat 2 with caption.png

past project - cultured meat 3 with caption.png

Naturbeads worked together with industrial partner Cellular Agriculture (UK) to develop and test a platform of prototype carriers for cell attachment, proliferation and differentiation. Our carriers have been tested successfully with: C2C12 cells (mouse myoblasts), pork fat cells, fish stem cells, and bovine satellite cells. This project is now in exploitation phase as we continue to sample companies interested in testing our carriers.

To request a sample, click here.

Collaboration with Vaxhub

Current projects

Naturbeads is working together with UCL and the German AI start-up Vitafluence to develop novel thermally stable vaccine formulations based on the cellulose microspheres. Thermally stable vaccine formulations decrease vaccine wastage and improve vaccine accessibility in areas of the world where it's difficult to ensure cold chain transportation.  The antigens used over the course of the project are ovalbumin, a model protein, and hemagglutinin, a well conserved protein in Influenza virus strains. Vitafluence offers an AI platform that could help model the interactions between the microspheres and novel antigens, potentially leading to a more rapid development of future vaccines.

Grant

Innovation & Scale-Up Support (Innovate UK)

4 Innovate UK grants totaling approximately £1.7 million, supporting the construction of two pilot plants and the expansion of applications from personal care and cosmetics to paints, coatings, and life science.

Government Research Projects (UK Contracts & Eureka)

2 UK government contracts worth £200K, funding research to test cellulose beads in biocatalysis, and a follow-up Eureka Project (£250K) advancing the technology to TRL 6.

Regional & Biomedical Research Grants (WECA & VaxHub)

1 WECA (West of England Combined Authority) and 1 VaxHub grant totaling £120K, supporting testing of Naturbeads microspheres as carriers in biomedical applications.